EXP WORLD HOLDINGS INC (EXPI)

US30212W1009 - Common Stock

11.82  -0.24 (-1.99%)

After market: 11.79 -0.03 (-0.25%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to EXPI. EXPI was compared to 64 industry peers in the Real Estate Management & Development industry. While EXPI has a great health rating, there are worries on its profitability. EXPI is quite expensive at the moment. It does show a decent growth rate.



3

1. Profitability

1.1 Basic Checks

In the past year EXPI has reported negative net income.
EXPI had a positive operating cash flow in the past year.
In multiple years EXPI reported negative net income over the last 5 years.
Each year in the past 5 years EXPI had a positive operating cash flow.

1.2 Ratios

EXPI has a Return On Assets of -7.62%. This is in the lower half of the industry: EXPI underperforms 61.90% of its industry peers.
The Return On Equity of EXPI (-15.61%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 2.80%, EXPI is in the better half of the industry, outperforming 74.60% of the companies in the same industry.
Industry RankSector Rank
ROA -7.62%
ROE -15.61%
ROIC 2.8%
ROA(3y)7.11%
ROA(5y)4.87%
ROE(3y)13.02%
ROE(5y)8.55%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

EXPI's Operating Margin of 0.17% is fine compared to the rest of the industry. EXPI outperforms 60.32% of its industry peers.
EXPI has a worse Gross Margin (7.51%) than 76.19% of its industry peers.
In the last couple of years the Gross Margin of EXPI has remained more or less at the same level.
Industry RankSector Rank
OM 0.17%
PM (TTM) N/A
GM 7.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.17%
GM growth 5Y-1.29%

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EXPI is destroying value.
The number of shares outstanding for EXPI has been increased compared to 1 year ago.
EXPI has more shares outstanding than it did 5 years ago.
There is no outstanding debt for EXPI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 15.34 indicates that EXPI is not in any danger for bankruptcy at the moment.
The Altman-Z score of EXPI (15.34) is better than 90.48% of its industry peers.
EXPI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 15.34
ROIC/WACC0.3
WACC9.22%

2.3 Liquidity

A Current Ratio of 1.40 indicates that EXPI should not have too much problems paying its short term obligations.
EXPI has a Current ratio (1.40) which is comparable to the rest of the industry.
EXPI has a Quick Ratio of 1.40. This is a normal value and indicates that EXPI is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of EXPI (1.40) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 1.4

4

3. Growth

3.1 Past

EXPI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -566.67%.
Looking at the last year, EXPI shows a small growth in Revenue. The Revenue has grown by 5.23% in the last year.
Measured over the past years, EXPI shows a very strong growth in Revenue. The Revenue has been growing by 53.64% on average per year.
EPS 1Y (TTM)-566.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-700%
Revenue 1Y (TTM)5.23%
Revenue growth 3Y33.53%
Revenue growth 5Y53.64%
Sales Q2Q%1.37%

3.2 Future

Based on estimates for the next years, EXPI will show a very strong growth in Earnings Per Share. The EPS will grow by 118.98% on average per year.
Based on estimates for the next years, EXPI will show a small growth in Revenue. The Revenue will grow by 4.92% on average per year.
EPS Next Y-197.5%
EPS Next 2Y168.58%
EPS Next 3Y118.98%
EPS Next 5YN/A
Revenue Next Year4.48%
Revenue Next 2Y6.07%
Revenue Next 3Y4.92%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

3

4. Valuation

4.1 Price/Earnings Ratio

EXPI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 37.79 indicates a quite expensive valuation of EXPI.
Based on the Price/Forward Earnings ratio, EXPI is valued a bit cheaper than the industry average as 74.60% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.99, EXPI is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 37.79

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as EXPI.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXPI indicates a rather cheap valuation: EXPI is cheaper than 93.65% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.94
EV/EBITDA 93.49

4.3 Compensation for Growth

A more expensive valuation may be justified as EXPI's earnings are expected to grow with 118.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y168.58%
EPS Next 3Y118.98%

3

5. Dividend

5.1 Amount

EXPI has a Yearly Dividend Yield of 1.72%.
Compared to an average industry Dividend Yield of 4.80, EXPI pays a better dividend. On top of this EXPI pays more dividend than 88.89% of the companies listed in the same industry.
EXPI's Dividend Yield is slightly below the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 1.72%

5.2 History

EXPI has been paying a dividend for less than 5 years, so it still needs to build a track record.
EXPI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3

5.3 Sustainability

EXPI has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-91.27%
EPS Next 2Y168.58%
EPS Next 3Y118.98%

EXP WORLD HOLDINGS INC

NASDAQ:EXPI (12/24/2024, 8:09:19 PM)

After market: 11.79 -0.03 (-0.25%)

11.82

-0.24 (-1.99%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)11-07 2024-11-07/dmh
Earnings (Next)02-20 2025-02-20/amc
Inst Owners38.12%
Inst Owner Change0.16%
Ins Owners47.81%
Ins Owner Change-1.72%
Market Cap1.81B
Analysts80
Price Target16.07 (35.96%)
Short Float %25.6%
Short Ratio25.57
Dividend
Industry RankSector Rank
Dividend Yield 1.72%
Dividend Growth(5Y)N/A
DP-91.27%
Div Incr Years3
Div Non Decr Years3
Ex-Date11-18 2024-11-18 (0.05)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-111.29%
Min EPS beat(2)-217.65%
Max EPS beat(2)-4.93%
EPS beat(4)1
Avg EPS beat(4)-90.07%
Min EPS beat(4)-217.65%
Max EPS beat(4)67.32%
EPS beat(8)2
Avg EPS beat(8)-56.32%
EPS beat(12)4
Avg EPS beat(12)6.45%
EPS beat(16)6
Avg EPS beat(16)12.03%
Revenue beat(2)0
Avg Revenue beat(2)-3.73%
Min Revenue beat(2)-5.29%
Max Revenue beat(2)-2.17%
Revenue beat(4)2
Avg Revenue beat(4)-0.86%
Min Revenue beat(4)-5.29%
Max Revenue beat(4)3.51%
Revenue beat(8)4
Avg Revenue beat(8)-2.11%
Revenue beat(12)6
Avg Revenue beat(12)-1.39%
Revenue beat(16)10
Avg Revenue beat(16)2.81%
PT rev (1m)6.78%
PT rev (3m)6.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-17.65%
EPS NY rev (1m)-1650%
EPS NY rev (3m)-1650%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.13%
Revenue NY rev (1m)-1.4%
Revenue NY rev (3m)-1.54%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 37.79
P/S 0.41
P/FCF 8.94
P/OCF 8.62
P/B 8.6
P/tB 9.82
EV/EBITDA 93.49
EPS(TTM)-0.14
EYN/A
EPS(NY)0.31
Fwd EY2.65%
FCF(TTM)1.32
FCFY11.18%
OCF(TTM)1.37
OCFY11.59%
SpS29
BVpS1.37
TBVpS1.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.62%
ROE -15.61%
ROCE 3.55%
ROIC 2.8%
ROICexc 7.33%
ROICexgc 10.85%
OM 0.17%
PM (TTM) N/A
GM 7.51%
FCFM 4.56%
ROA(3y)7.11%
ROA(5y)4.87%
ROE(3y)13.02%
ROE(5y)8.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.17%
GM growth 5Y-1.29%
F-Score5
Asset Turnover10.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 70.53%
Cap/Sales 0.17%
Interest Coverage 250
Cash Conversion 1167.89%
Profit Quality N/A
Current Ratio 1.4
Quick Ratio 1.4
Altman-Z 15.34
F-Score5
WACC9.22%
ROIC/WACC0.3
Cap/Depr(3y)136.41%
Cap/Depr(5y)156.34%
Cap/Sales(3y)0.27%
Cap/Sales(5y)0.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-566.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-700%
EPS Next Y-197.5%
EPS Next 2Y168.58%
EPS Next 3Y118.98%
EPS Next 5YN/A
Revenue 1Y (TTM)5.23%
Revenue growth 3Y33.53%
Revenue growth 5Y53.64%
Sales Q2Q%1.37%
Revenue Next Year4.48%
Revenue Next 2Y6.07%
Revenue Next 3Y4.92%
Revenue Next 5YN/A
EBIT growth 1Y1147.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2030.57%
EBIT Next 3Y219.06%
EBIT Next 5YN/A
FCF growth 1Y-8.72%
FCF growth 3Y21.09%
FCF growth 5Y55.4%
OCF growth 1Y-10.76%
OCF growth 3Y20.44%
OCF growth 5Y53.8%